Phase I Clinical Trial of Gene-Edited Cells for Cancer Proves Safe and Durable

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


CRISPR-Cas9-edited T cells could be used to boost the immune response against cancer. | McGovern Institute for Brain Research at MIT
https://www.aaas.org/news/phase-i-clinical-trial-gene-edited-cells-cancer-proves-safe-and-durable

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.